The American Society for Bone & Mineral Research 35th Annual Meeting has just concluded. Of the roughly 2000 attendees, nearly half were form other countries. Most are PhD researchers dealing in basic science issues and then moving toward answers to human maladies. Two totally new types of osteoporosis medications are in phase 3 human trials. They look promising.
Those of us who treat human patients use meetings to trade information. My poster about using Vertebral Fracture Assessment to improve the accuracy of DXA was well received. Many academic osteoporosis centers routinely use VFA, but have not yet analyzed and reported their results. I learned a lot from other attendees, much of which will help me help my patients.
Several symposia were about topics which have been in the news in the last year. Complete information is hard to fit in a headline. Many individual presentations were “one more piece to the puzzle” that made the big picture a little clearer. I will attempt to cover them in future posts.
By attending ASBMR I have gathered information to pass on to you. You will be able use to that information to take control of your bone health.
Jay Ginther, MD
TagsAmerican Society for Bone & Mineral ResearchASBMRBone HealthCalciumDXAOsteoporosis medicationVertebral Fracture AssessmentVFA
Categorised in: Bone Health